Hennion & Walsh Asset Management »

Protagonist Therapeutics shares owned by Hennion & Walsh Asset Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Hennion & Walsh Asset Management from 13F filings

Historical chart of Hennion & Walsh Asset Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Hennion & Walsh Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Hennion & Walsh Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.3M 26k 48.36
2024-12-31 $1.2M 32k 38.60
2024-09-30 $1.7M 37k 45.00
2024-06-30 $1.3M 38k 34.65
2024-03-31 $1.0M 35k 28.93
2023-12-31 $781k 34k 22.93
2023-09-30 $528k 32k 16.68
2023-06-30 $461k 17k 27.59

More positions owned by Hennion & Walsh Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Wisdomtree Tr Dynamic Intl Eqt (DDWM)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Proshares Tr S&p 500 High Inc (ISPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Investment Grade (IGEB)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)
Ishares Tr Pfd And Incm Sec (PFF)
Pimco Municipal Income Fund II (PML)
Alphabet Cap Stk Cl A (GOOGL)
Nuveen Muni Value Fund (NUV)

View all positions for Hennion & Walsh Asset Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
BVF
Johnson & Johnson
Wellington Management Company
UBS Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics